UTMC Among First Hospitals Participating in National COVID-19 Drug Study

January 6, 2021 | COVID-19, UToledo in the News, UTMC
By Tyrel Linkhorn



Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about the importance of developing new COVID-19 therapies and how UTMC is playing a role by participating in a nationwide NIH study of experimental treatments.

Click to access the login or register cheese